AI assistant
Sending…
Calidi Biotherapeutics, Inc. — Director's Dealing 2021
Sep 10, 2021
35284_dirs_2021-09-09_5a92c98e-d966-4c8d-9fd3-018cd1f18c19.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: First Light Acquisition Group, Inc. (FLAG)
CIK: 0001855485
Period of Report: 2021-09-09
Reporting Person: RUETTGERS MICHAEL C (N/A)
More from Calidi Biotherapeutics, Inc.
Capital/Financing Update
2026
May 29
Regulatory Filings
2026
May 14
Capital/Financing Update
2026
May 8
Annual Report
2026
Mar 27
Earnings Release
2026
Mar 27
Investor Presentation
2026
Feb 10
Major Shareholding Notification
2026
Feb 10
Major Shareholding Notification
2026
Feb 4
Regulatory Filings
2026
Jan 28
Director's Dealing
2025
Dec 17